Premium
Birthweight and Childhood Cancer: Preliminary Findings from the I nternational C hildhood C ancer C ohort C onsortium ( I4C )
Author(s) -
Paltiel Ora,
Tikellis Gabriella,
Linet Martha,
Golding Jean,
Lemeshow Stanley,
Phillips Gary,
Lamb Karen,
Stoltenberg Camilla,
Håberg Siri E.,
Strøm Marin,
Granstrøm Charlotta,
Northstone Kate,
Klebanoff Mark,
Ponsonby AnneLouise,
Milne Elizabeth,
Pedersen Marie,
Kogevinas Manolis,
Ha Eunhee,
Dwyer Terence
Publication year - 2015
Publication title -
paediatric and perinatal epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 88
eISSN - 1365-3016
pISSN - 0269-5022
DOI - 10.1111/ppe.12193
Subject(s) - medicine , hazard ratio , confidence interval , cancer , gestational age , cohort , pediatrics , birth weight , demography , pregnancy , obstetrics , sociology , biology , genetics
Background Evidence relating childhood cancer to high birthweight is derived primarily from registry and case–control studies. We aimed to investigate this association, exploring the potential modifying roles of age at diagnosis and maternal anthropometrics, using prospectively collected data from the I nternational C hildhood C ancer C ohort C onsortium. Methods We pooled data on infant and parental characteristics and cancer incidence from six geographically and temporally diverse member cohorts [the Avon Longitudinal Study of Parents and Children (UK), the Collaborative Perinatal Project (USA), the Danish National Birth Cohort (Denmark), the Jerusalem Perinatal Study (Israel), the Norwegian Mother and Child Cohort Study (Norway), and the Tasmanian Infant Health Survey (Australia)]. Birthweight metrics included a continuous measure, deciles, and categories (≥4.0 vs. <4.0 kilogram). Childhood cancer (377 cases diagnosed prior to age 15 years) risk was analysed by type (all sites, leukaemia, acute lymphoblastic leukaemia, and non‐leukaemia) and age at diagnosis. We estimated hazard ratios ( HR ) and 95% confidence intervals ( CI ) from C ox proportional hazards models stratified by cohort. Results A linear relationship was noted for each kilogram increment in birthweight adjusted for gender and gestational age for all cancers [ HR = 1.26; 95% CI 1.02, 1.54]. Similar trends were observed for leukaemia. There were no significant interactions with maternal pre‐pregnancy overweight or pregnancy weight gain. Birthweight ≥4.0 kg was associated with non‐leukaemia cancer among children diagnosed at age ≥3 years [ HR = 1.62; 95% CI 1.06, 2.46], but not at younger ages [ HR = 0.7; 95% CI 0.45, 1.24, P for difference = 0.02]. Conclusion Childhood cancer incidence rises with increasing birthweight. In older children, cancers other than leukaemia are particularly related to high birthweight. Maternal adiposity, currently widespread, was not demonstrated to substantially modify these associations. Common factors underlying foetal growth and carcinogenesis need to be further explored.